Advanced search
Publication Cover
Infectious Diseases Volume 47, 2015 - Issue 9
Submit an article Journal homepage
131
Views
5
CrossRef citations to date
0
Altmetric
LETTER TO THE EDITOR

Patterns of outpatient ceftriaxone use in a Japanese general hospital: an increased need for development of outpatient parenteral antimicrobial therapy programs

Ryota HaseFrom the Department of Infectious Diseases, Kameda Medical Center, Kamogawa, Chiba, JapanCorrespondence[email protected]
&
Naoto HosokawaFrom the Department of Infectious Diseases, Kameda Medical Center, Kamogawa, Chiba, Japan
Pages 668-671 | Received 20 Feb 2015, Accepted 09 Mar 2015, Published online: 08 Apr 2015

References

  • Rucker RW, Harrison GM. Outpatient intravenous medications in the management of cystic fibrosis. Pediatrics 1974;54:358–60.
  • Howden BP, Grayson ML. 5: Hospital-in-the-home treatment of infectious diseases. Med J Aust 2002;176: 440–5.
  • Muldoon EG, Allison GM, Gallagher D, Snydman DR, Bergin C. Outpatient parenteral antimicrobial therapy (OPAT) in the Republic of Ireland: results of a national survey. Eur J Clin Microbiol Infect Dis 2013;32:1465–70.
  • Tice AD, Rehm SJ, Dalovisio JR, Bradley JS, Martinelli LP, Graham DR, et al. Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines. Clin Infect Dis 2004;38:1651–72.
  • Chapman AL, Seaton RA, Cooper MA, Hedderwick S, Goodall V, Reed C, et al. Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement. J Antimicrob Chemother 2012;67:1053–62.
  • Esposito S, Noviello S, Leone S, Tice A, Seibold G, Nathwani D, et al. Outpatient parenteral antibiotic therapy (OPAT) in different countries: a comparison. Int J Antimicrob Agents 2004;24:473–8.
  • Yan YM, Singh M, Tonks K, Kavi J, Langford NJ. Delivering outpatient antibiotic therapy (OPAT) in an Acute Medical Unit. Acute Med 2011;10:22–5.
  • Barr DA, Semple L, Seaton RA. Outpatient parenteral antimicrobial therapy (OPAT) in a teaching hospital-based practice: a retrospective cohort study describing experience and evolution over 10 years. Int J Antimicrob Agents 2012;39:407–13.
  • Seetoh T, Lye DC, Cook AR, Archuleta S, Chan M, Sulaiman Z, et al. An outcomes analysis of outpatient parenteral antibiotic therapy (OPAT) in a large Asian cohort. Int J Antimicrob Agents 2013;41:569–73.
  • Vesteinsdottir I, Gudlaugsdottir S, Einarsdottir R, Kalaitzakis E, Sigurdardottir O, Bjornsson ES. Risk factors for Clostridium difficile toxin-positive diarrhea: a population-based prospective case-control study. Eur J Clin Microbiol Infect Dis 2012;31:2601–10.
  • Thomas C, Riley TV. Restriction of third generation cephalosporin use reduces the incidence of Clostridium difficile-associated diarrhoea in hospitalised patients. Commun Dis Intell Q Rep 2003;27(Suppl):S28–31.
  • Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 2001;32:1162–71.
  • Paterson DL, Ko WC, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H, et al. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial Infections. Ann Intern Med 2004;140:26–32.
  • McKinnell JA, Kunz DF, Chamot E, Patel M, Shirley RM, Moser SA, et al. Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usage. Infect Control Hosp Epidemiol 2012;33:718–24.
  • Fridkin SK, Edwards JR, Courval JM, Hill H, Tenover FC, Lawton R, et al. The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units. Ann Intern Med 2001;135:175–83.
  • Fukatsu K, Saito H, Matsuda T, Ikeda S, Furukawa S, Muto T. Influences of type and duration of antimicrobial prophylaxis on an outbreak of methicillin-resistant Staphylococcus aureus and on the incidence of wound infection. Arch Surg 1997;132:1320–5.
  • Washio M, Mizoue T, Kajioka T, Yoshimitsu T, Okayama M, Hamada T, et al. Risk factors for methicillin-resistant Staphylococcus aureus (MRSA) infection in a Japanese geriatric hospital. Public Health 1997;111:187–90.
  • Sharma R, Loomis W, Brown RB. Impact of mandatory inpatient infectious disease consultation on outpatient parenteral antibiotic therapy. Am J Med Sci 2005;330:60–4.
  • Duncan CJ, Barr DA, Seaton RA. Outpatient parenteral antimicrobial therapy with ceftriaxone, a review. Int J Clin Pharm 2012;34:410–17.
  • OECD. Health at a Glance 2013: OECD Indicators, OECD Publishing. Available from: http://dx.doi.org/10.1787/health_glance-2013-en
  • Hase R, Hosokawa N, Uno S, Mikawa T, Uwamino Y, Muranaka K. The first trial of OPAT (outpatient parenteral antimicrobial therapy) with continuous infusions in Japan. Kansenshogaku Zasshi 2014;88:269–74.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.